CI
Contraline, Inc.
SEC filingBiotechnology · Charlottesville, VA
Amount raised$55.8Msold at filing
Total offering$115.9M$60.1M still open
Investors in the raise77count reported to the SEC
FiledJun 10, 2026first sale May 29, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kevin S EisenfratsExecutive Officer, Director, Promoter
Iris J Van Alderwerelt van RosenburghDirector
Martin J EmersonDirector
Gurdane J BhutaniDirector
Executive officers, directors and promoters as listed on the Form D.